Form 4: Hinge Health Co-Founder Gabriel Mecklenburg Adjusts Holdings Post-IPO Reclassification

Hinge Health, Inc. Executive Chairman and Co-Founder Gabriel M.I. Mecklenburg reported significant changes in his beneficial ownership, including a reclassification of common stock into Class B shares and a disposal of shares for tax obligations.

Summary

• Gabriel M.I. Mecklenburg, Director, Executive Chairman & Co-Founder of Hinge Health, Inc. (HNGE), filed a Form 4 detailing changes in his beneficial ownership.
• On March 7, 2025, Mr. Mecklenburg gifted 1,475,711 shares of Common Stock directly, and acquired 1,092,119 shares indirectly via a GRAT and 383,592 shares indirectly via a Family Trust, all at a price of $0.
• On May 21, 2025, Mr. Mecklenburg disposed of 1,957,003 shares of Common Stock directly at a price of $32 per share to satisfy tax withholding obligations.
• On May 23, 2025, immediately prior to the Issuer's initial public offering, 2,627,211 shares of Common Stock (direct), 1,092,119 shares (indirect via GRAT), and 383,592 shares (indirect via Family Trust) were reclassified into Class B Common Stock in an exempt transaction pursuant to Rule 16b-7.
• Each share of Class B Common Stock is convertible at any time into one share of Class A Common Stock and will automatically convert upon certain events as described in the Issuer's amended and restated certificate of incorporation.
• The reported holdings include 944,250 Performance Stock Units (PSUs), each representing a contingent right to receive one share of Class B Common Stock, vesting according to award terms.
• Several stock options, with exercise prices ranging from $0.30 to $1.90, were also reclassified from Common Stock to Class B Common Stock on May 23, 2025; these options are fully vested and currently exercisable.

Sentiment

Score: 5

Explanation: The document is a factual report of insider transactions and a corporate reclassification, providing no direct positive or negative sentiment regarding the company's operational or financial performance.

Positives

• The reporting person, a co-founder and executive chairman, maintains a substantial beneficial ownership stake in the company, primarily through Class B Common Stock.
• A significant portion of the reporting person's stock options are fully vested and currently exercisable, representing potential future value.
• The reclassification into Class B Common Stock, often associated with enhanced voting rights for founders, indicates continued control and long-term commitment from key management.

Negatives

• The disposal of 1,957,003 shares of Common Stock at $32 per share to cover tax liabilities resulted in a reduction of direct common stock holdings.

Risks

• The reclassification of shares into Class B Common Stock, which typically carries super-voting rights, could concentrate voting power with founders and potentially limit the influence of Class A shareholders on corporate decisions.

Future Outlook

The document primarily reports past transactions and reclassifications related to the company's initial public offering (IPO) and does not provide specific forward-looking statements or guidance on future financial performance.

Management Comments

• "These securities were previously reported on a Form 3 filed by the Reporting Person."
• "Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock held by the Issuer's founders and certain related individuals, including shares of Common Stock underlying performance stock unit ('PSU') and stock options awards, were reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7."
• "Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation."
• "Includes 944,250 PSUs, which vest in accordance with the terms of the award. Each PSU represents a contingent right to receive one share of Class B Common Stock."
• "The stock option is fully vested and currently exercisable."

Industry Context

This Form 4 filing details insider transactions and a stock reclassification event, which is a common occurrence for companies undergoing an initial public offering (IPO) to establish a dual-class share structure, often seen in technology and growth companies to maintain founder control.

Corporate Governance

Related Party Transactions

• Gift of 1,092,119 shares of Common Stock to a Grantor Retained Annuity Trust (GRAT) on March 7, 2025.
• Gift of 383,592 shares of Common Stock to a Family Trust on March 7, 2025.

Stakeholder Impact

• **Shareholders:** The reclassification of founder shares into Class B Common Stock may impact the voting power dynamics, potentially concentrating control with the founders. The disposal of shares for tax purposes by a key insider could be noted by investors, though it's a common practice.
• **Management (Reporting Person):** The transactions reflect a restructuring of the co-founder's ownership stake, maintaining significant beneficial interest primarily through Class B shares and vested options, aligning their long-term interests with the company's success.

Key Dates

Keywords

Hinge Health, HNGE, Form 4, Insider Trading, Beneficial Ownership, Stock Reclassification, Class B Common Stock, Stock Options, Performance Stock Units, Corporate Governance, IPO